Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence [Clinical Sciences]
Conclusions—The composite risk of stroke and transient ischemic attack reduced in the postrandomized LDL cholesterol level of 80 to 100 mg/dL after adjusting for statin usage.Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00221104.
Source: Stroke - Category: Neurology Authors: Naohisa Hosomi, Kazuo Kitagawa, Yoji Nagai, Yoko Nakagawa, Shiro Aoki, Tomohisa Nezu, Tatsuo Kagimura, Hirofumi Maruyama, Hideki Origasa, Kazuo Minematsu, Shinichiro Uchiyama, Masayasu Matsumoto Tags: Lipids and Cholesterol, Secondary Prevention, Treatment Original Contributions Source Type: research
More News: Cholesterol | Clinical Trials | Diabetes | Diabetes Mellitus | Endocrinology | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Japan Health | Pravastatin | Statin Therapy | Stroke | Study